Open-house rebate agreement for Chlortalidon

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Oct 05, 2026 · 38 days left·Open·Supplies·Framework

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04

58/100

Opportunity Score

Needs reviewMedium complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

58 / 100

Complexity

42 / 100

Risk factors

For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...

Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Nov 2026
Non-exclusive rebate agreements for pharmaceutical products containing Chlortalidon (ATC C03BA04).
Open-house model with identical, pre-set contract terms for all eligible pharmaceutical companies.

Show full summary

Open-house supply arrangement for pharmaceutical products: AOK Bayern seeks non-exclusive rebate agreements for the active substance Chlortalidon (ATC C03BA04). The model is explicitly described as open-house, with no selection among bidders and identical non-negotiable contract terms for all eligible pharmaceutical companies. The notice provides clear submission routes and a monthly accession mechanism, but no contract value is stated.

Risks

For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...

Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

Only pharmaceutical companies are eligible as potential contract partners.

Administrative

Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
Submission of the signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Chlortalidon

Single lot for non-exclusive pharmaceutical rebate agreements covering Chlortalidon (ATC C03BA04). Scope is supplies of pharmaceutical products under an open-house model; contract terms are identical and not individually negotiable. Performance is in Germany, specifically Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Nov 2024 - Nov 2026

Procurement Details

Publication date: 16 Oct 2024
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 628089-2024

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3